leisure time -WSS

leisure time

author：focus 2025-09-06 04:33:52 - browse：2942

3d rendered medically accurate illustration of the adrenal gland – biotech and pharma coverage from STAT — Adobe

SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial, bringing the company a step closer to treating patients with a rare and serious set of genetic disorders that alters their ability to produce key hormones.

In the Phase 3 study, known as CAHtalyst, 182 adults were randomly assigned to receive a placebo or crinecerfont, an oral drug Neurocrine developed to lower male sex hormones patients with the disease produce in excess. Researchers found that, compared to those on placebo, participants who took crinecerfont needed a significantly lower dose of the current standard-of-care treatment, glucocorticoids, after 24 weeks of treatment that they did at the study’s start. And about 63% of participants who took crinecerfont were able to lower their dose of glucocorticoids to levels researchers think would be safer for prolonged use, compared to 18% of those on the placebo.

Neurocine, a San Diego biotech focused on treating rare neurological and endocrine diseases, believes the drug could allow people living with congenital adrenal hyperplasia, or CAH, to avoid some of the more serious side effects of glucocorticoids by allowing them to take lower doses. Long-term use of high doses of these drugs can cause patients to gain weight and put them at risk of diabetes, heart disease, and osteoporosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

WSS

FDA seeks to regulate lab

Texas Department of Public Safety speaks out on migrant abuse allegations

How one patient went off dialysis — and others can too

Judge rejects Trump's request to move Stormy Daniels hush

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Senator probes 340B programs at Cleveland Clinic, Bon Secours

focus

leisure time

Wikipedia

Medicare details structure of new drug price negotiation program

Why do women spend more than men on medical expenses?

Drug repurposing or repositioning? The language matters

Why Congress must ban federal programs from using QALYs

23andMe had bad news about my health. I wish a person had delivered it

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

How to save PrEP access — and even expand it

WHO recommends dropping component of many flu vaccines

Guidelines to prevent youth baseball injuries need more muscle

Sudafed saga points to U.S. issues with evaluating older drugs

hotspot

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Stanford president faces new allegations over 1999 paper

Researchers use wearables data and AI to predict preterm birth risk

How the Dana

Driven by the pandemic, applicants flood public health schools

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

knowledge

Wikipedia

hotspot

explore